As a member institution of the Gynecologic Oncology Group (GOG), a multi-institutional clinical research group funded by the National Cancer Institute, Washington University is able to provide the latest cancer treatment options. More than 40 treatment protocols are available, including investigational drugs not offered outside of GOG institutions. Washington University is one of six centers designated to test Phase I studies for the GOG, and it also participates in multiple protocols sponsored by pharmaceutical companies.
Treatment protocols also are offered through the Mallinckrodt Institute of Radiology, through its membership in the Radiation Therapy Oncology Group, a clinical research group dedicated to research utilizing radiation therapy techniques.
Learn more about a specific cancer type at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.